Works matching IS 17562856 AND DT 2012 AND VI 5 AND IP 1
Results: 5
Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2012, v. 5, n. 1, p. 3, doi. 10.1177/1756285611428503
- By:
- Publication type:
- Article
Smoking: effects on multiple sclerosis susceptibility and disease progression.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2012, v. 5, n. 1, p. 13, doi. 10.1177/1756285611425694
- By:
- Publication type:
- Article
Nonmotor outcomes in Parkinson’s disease: is deep brain stimulation better than dopamine replacement therapy?
- Published in:
- Therapeutic Advances in Neurological Disorders, 2012, v. 5, n. 1, p. 23, doi. 10.1177/1756285611423412
- By:
- Publication type:
- Article
Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2012, v. 5, n. 1, p. 43, doi. 10.1177/1756285611422267
- By:
- Publication type:
- Article
Occipital nerve stimulation in primary headache syndromes.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2012, v. 5, n. 1, p. 57, doi. 10.1177/1756285611420903
- By:
- Publication type:
- Article